For more information about West, please visit our website: www.westpharma.com. For more information about the PDA Universe of Pre-Filled Syringes and Injection Devices Conference, please visit: 2023 ...
As we anticipate the upcoming annual PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix this 22-23 October, we caught up with a member of the planning committee to get a ...
Pre-filled syringes are easy to use; they ensure exact dosages, so that patients can conveniently inject their own medications. These syringes have become commonplace in therapies for the widest ...
POMONA, Calif., Feb. 3, 2026 /PRNewswire/ -- Amsino International, Inc. is pleased to announce a new three-year partnership with Partners Cooperative, effective January 1, 2026. This agreement ...
WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...
Catalent’s CTLT shares surged 11.3% on Wednesday following the company’s promising update related to its pre-filled syringes. CTLT expects the booming demand for approved weight-loss drugs to keep the ...
NEWARK, Del.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL silicone-free* GORE® IMPROJECT® ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 16, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's New Drug ...
Alkem Laboratories has brought in semaglutide in single-shot pre-filled syringes, in multiple dose strengths, starting at ₹350, the company said. The company had received the regulatory Drugs ...
EXTON, Pa., Oct. 18, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results